Literature DB >> 10348774

Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections.

E J Goldstein1, D M Citron, C V Merriam, K Tyrrell, Y Warren.   

Abstract

The activity of gatifloxacin against 308 aerobes and 112 anaerobes isolated from bite wound infections was studied. Gatifloxacin was active at </=0.016 microg/ml against all 148 Pasteurella isolates (eight species and three subspecies) tested and all other aerobes tested, including Actinobacillus-Haemophilus spp., Eikenella corrodens, Neisseria weaveri, Weeksella zoohelcum, staphylococci, and streptococci. Fusobacteria were sometimes resistant. Gatifloxacin MICs at which 90% of the isolates were inhibited were 0. 125 microg/ml against Bacteroides tectum and Prevotella spp., 0.25 microg/ml against Porphyromonas spp., and 0.5 microg/ml against peptostreptococci.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10348774      PMCID： PMC89300          DOI： 10.1128/AAC.43.6.1475

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Pasteurella multocida: bilateral septic knee joint prostheses from a distant cat bite.

Authors:  D W Orton; W H Fulcher
Journal:  Ann Emerg Med       Date:  1984-11       Impact factor: 5.721

2.  Erythromycin failure with subsequent Pasteurella multocida meningitis and septic arthritis in a cat-bite victim.

Authors:  J M Levin; D A Talan
Journal:  Ann Emerg Med       Date:  1990-12       Impact factor: 5.721

3.  Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms.

Authors:  L M Ednie; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

Review 4.  Bite wounds and infection.

Authors:  E J Goldstein
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

5.  In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.

Authors:  E Wakabayashi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

6.  Bacteriology of human and animal bite wounds.

Authors:  E J Goldstein; D M Citron; B Wield; U Blachman; V L Sutter; T A Miller; S M Finegold
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

7.  In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.

Authors:  M Hosaka; T Yasue; H Fukuda; H Tomizawa; H Aoyama; K Hirai
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

8.  Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

9.  Characterization and distribution of Pasteurella species recovered from infected humans.

Authors:  E Holst; J Rollof; L Larsson; J P Nielsen
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

10.  Microbiology of human and animal bite wounds in children.

Authors:  I Brook
Journal:  Pediatr Infect Dis J       Date:  1987-01       Impact factor: 2.129
View more
  15 in total

1.  In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria.

Authors:  R Schaumann; G Ackermann; B Pless; M C Claros; A C Rodloff
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

2.  Postoperative care of the facial laceration.

Authors:  Nicholas Medel; Neeraj Panchal; Edward Ellis
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2010-12

3.  Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens.

Authors:  Diane M Citron; Yumi A Warren; Helen T Fernandez; Maurice A Goldstein; Kerin L Tyrrell; Ellie J C Goldstein
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

4.  Periodontal bacteria in rabbit mandibular and maxillary abscesses.

Authors:  Kerin L Tyrrell; Diane M Citron; Jeffrey R Jenkins; Ellie J C Goldstein
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 5.  Gatifloxacin: a review of its use in the management of bacterial infections.

Authors:  Caroline M Perry; Douglas Ormrod; Miriam Hurst; Susan V Onrust
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  A critical review of the fluoroquinolones: focus on respiratory infections.

Authors:  George G Zhanel; Kelly Ennis; Lavern Vercaigne; Andrew Walkty; Alfred S Gin; John Embil; Heather Smith; Daryl J Hoban
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 7.  A practical guide to the treatment of complicated skin and soft tissue infections.

Authors:  Horatio B Fung; Joanne Y Chang; Stephen Kuczynski
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  The Role of Fluoroquinolones in the Treatment of Skin and Soft Tissue Infection.

Authors:  Md Rabiul Alam; Ellie Hershberger; Marcus J. Zervos
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

9.  In vitro activities of new fluoroquinolones against Campylobacter jejuni and Campylobacter coli isolates obtained from humans in 1980 to 1982 and 1997 to 2001.

Authors:  Rea Krausse; Uwe Ullmann
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

10.  Management of human and animal bite wound infection: an overview.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.